Diabetes News Hound

As we reported on Tuesday, the Artificial Pancreas project is making significant progress and may be available in just a few years (see: Artificial Pancreas May Be Right Around the Corner). Researchers speaking at the American Diabetes Association’s (ADA) meeting in Orlando, Florida noted they recently completed a study in which patients using an artificial pancreas overnight were able to improve their blood sugar control without a greater risk of a hypoglycemic event. So, what’s next? (more…)

Researchers from the Washington University School of Medicine working with pig pancreatic cells say they have made a major breakthrough in the path towards a cure to Type 1 diabetes (more…)

A group of researchers from across Europe and North American say they have found 12 new genetic links to Type 2 diabetes, according to a recent article from Reuters. They say the findings not only help them understand the factors behind the disease,  but also holds important clues for developing new treatments and medicines. (more…)

Researchers have long sought to understand the exact cause of Type 1 diabetes. Now, scientists at Northwestern University say they believe it is due to a malfunction into the pancreas’ “circadian clock,” (more…)

Researchers have gained regulatory clearance for a Phase I/ II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in patients with Type 1 diabetes (more…)

A once-a-week injection called exenatide may be better than daily insulin glargine shots for people with Type 2 diabetes that still have poor blood sugar control despite using front line diabetes drugs (more…)

The artificial pancreas, the holy grail of Type 1 diabetes blood sugar management and what many consider to be the next best thing to a cure, may be available in just a few years (more…)

Medical advances have helped people with Type 1 diabetes live much longer lives than in the past, but they still have a much higher mortality rate than  the general population (more…)

Researchers said they have developed dapagliflozin, a new kind of Type 2 diabetes drug (more…)